Huang W, Chung UI, Kronenberg HM, de Crombrugghe B (2001) The chondrogenic transcription factor Sox9 is a target of signaling by the parathyroid hormone-related peptide in the growth plate of endochondral bones. Proc Natl Acad Sci U S A 98, 160-5 11120880

This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.

Click on the protein name to open the protein page, and on the RSD number to open the site page.

Download

S181-p - SOX9 (human) ▲

Modsite: YQPRRRKsVKNGQAE SwissProt Entrez-Gene Orthologous residues SOX9 (human): S181‑p, SOX9 (mouse): S181‑p, SOX9 (rat): S181‑p, SOX9 (chicken): S181‑p Characterization Methods used to characterize site in vivo:  phospho-antibody Relevant cell lines - cell types - tissues:  COS (fibroblast) Cellular systems studied:  cell lines Species studied:  green monkey Upstream Regulation Treatments, proteins and their effect on site modification:  Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes PTHrP PTHR (human) increase H-89 PTHrP PTHR (human) inhibit treatment-induced increase okadaic_acid PTHrP PTHR (human) no effect upon treatment-induced increase